These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study. Pan CW, Shen ZJ, Ding GQ. J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576 [Abstract] [Full Text] [Related]
29. Tumor cytokinetics in the presence of normal, alloimmune, or Bacillus Calmette-Guérin-activated host cells simultaneously assayed in vivo and in vitro. Normann SJ, Cornelius J. Cancer Res; 1987 Apr 15; 47(8):2067-72. PubMed ID: 3828996 [Abstract] [Full Text] [Related]
30. Dose-dependent adjuvant effects of Bacillus Calmette-Guérin on tumor immunity in Lewis rats. Davies M, Sabbadini E. Cancer Res; 1979 Mar 15; 39(3):959-65. PubMed ID: 311684 [Abstract] [Full Text] [Related]
31. Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery. Ashley MP, Zbar B, Hunter JT, Rapp HJ, Sugimoto T. Cancer Res; 1980 Nov 15; 40(11):4197-203. PubMed ID: 7471060 [Abstract] [Full Text] [Related]
32. The effect of Mycobacterium bovis (Bacillus Calmette-Guérin) on macrophage random migration, chemotaxis, and pinocytosis. Poplack DG, Sher NA, Chaparas SD, Blaese RM. Cancer Res; 1976 Apr 15; 36(4):1233-7. PubMed ID: 769964 [Abstract] [Full Text] [Related]
33. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment. Alvarez V, Lodillinsky C, Umerez S, Sandes E, Eiján AM. Int J Mol Med; 2005 Oct 15; 16(4):565-71. PubMed ID: 16142388 [Abstract] [Full Text] [Related]